Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas.
about
Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.Transforming growth factors-beta are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system.Is telomerase reactivation associated with the down-regulation of TGF beta receptor-II expression in human breast cancer?Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-betaInvestigation of three new mouse mammary tumor cell lines as models for transforming growth factor (TGF)-beta and Neu pathway signaling studies: identification of a novel model for TGF-beta-induced epithelial-to-mesenchymal transitionTGF-β - an excellent servant but a bad masterAttenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesisTransforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cellsReciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells.The type III TGF-beta receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-beta signaling.Epigenetic Targeting of Transforming Growth Factor β Receptor II and Implications for Cancer TherapyTGF- β: an important mediator of allergic disease and a molecule with dual activity in cancer development.Transforming growth factor beta and its receptors: their role in breast cancer.Identification of a novel TGFβ/PKA signaling transduceome in mediating control of cell survival and metastasis in colon cancer.Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics.Evaluation of the prognostic value of TGF-β superfamily type I receptor and TGF-β type II receptor expression in nasopharyngeal carcinoma using high-throughput tissue microarrays.Distinctive mechanism for sustained TGF-β signaling and growth inhibition: MEK1 activation-dependent stabilization of type II TGF-β receptors.MicroRNA-301a promotes migration and invasion by targeting TGFBR2 in human colorectal cancer.Increased pSmad2 expression and cytoplasmic predominant presence of TGF-βRII in breast cancer tissue are associated with poor prognosis: results from the Shanghai Breast Cancer Study.The two faces of transforming growth factor beta in carcinogenesisHistone deacetylase inhibitor belinostat represses survivin expression through reactivation of transforming growth factor beta (TGFbeta) receptor II leading to cancer cell death.TGF-β receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanismsClinical Implications of TβRII Expression in Breast Cancer.TGFβ isoforms and receptors mRNA expression in breast tumours: prognostic value and clinical implicationsTGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression.TR4 nuclear receptor increases prostate cancer invasion via decreasing the miR-373-3p expression to alter TGFβR2/p-Smad3 signals.A functional polymorphism of TGFBR2 is associated with risk of breast cancer with ER(+), PR(+), ER(+)PR(+) and HER2(-) expression in women.Proteomics of TGF-beta signaling and its impact on breast cancer.Expression of CDKN1A/p21 and TGFBR2 in breast cancer and their prognostic significance.Determination of TGFbeta1 protein level in human primary breast cancers and its relationship with survival.Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft modelLoss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype.Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer.Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?Erbin and the NF2 tumor suppressor Merlin cooperatively regulate cell-type-specific activation of PAK2 by TGF-beta.Transforming growth factor-β signaling in tumor initiation, progression and therapy in breast cancer: an update.Association of overexpression of TIF1γ with colorectal carcinogenesis and advanced colorectal adenocarcinoma.Hyaluronan attenuates transforming growth factor-beta1-mediated signaling in renal proximal tubular epithelial cells.Reduced expression of activin receptor-like kinase 7 in breast cancer is associated with tumor progression.Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells.
P2860
Q22000749-04ECF3D4-947D-469C-A072-360ED6E96A1AQ24791032-39949677-BA1C-4CE7-9161-1574D0E10BBDQ24791742-BE2C1A5B-ED35-4BEE-B413-FDA4AB89C660Q24793319-D0228185-53FB-4C38-A9FD-0241AAE19C50Q24806331-86E224B1-D28C-4158-9C95-439289F3A88AQ27025590-ADA8B3A8-A6D9-46F0-A47E-0076FF789C34Q28386225-3C30315A-E434-4DA8-969D-E414A4733BCFQ30529353-8156A19C-34D4-4663-AF9B-CB9AB85323AAQ30540998-1E37B870-430D-4EF6-A76D-090C3F4F7CA3Q33615313-4D378566-8AEE-4450-924C-DFAE21CD4776Q33802356-90728755-AC7B-4C90-BDDE-4036D7C8CB5BQ33809976-CA6533DD-1613-44BE-8F6E-AD4E07ABCD2FQ33836101-37E4F9BA-853A-4C07-86A6-FC7ED76F3B6AQ33894754-72DADB38-F66A-42BB-995F-E333A9D32CDAQ34157940-0CAA6207-7753-447B-82F8-1C5AAC7CF357Q34185183-E7733B04-8B62-489D-863F-878ED8A80A61Q34793617-C81DB095-3DF9-421C-B168-B4356C906559Q35005275-570C42B0-3BB3-4B71-A73E-EFCC23F862EDQ35027906-BB274611-62EA-4F69-B866-781CE4DB14B2Q35170231-1EF52C54-5394-4199-9379-62CD7C77D400Q35183027-DB1C1F70-D2E5-4D0D-9B0A-3BE1AAADC89EQ35814020-842D386D-7893-48B0-9D2B-392C24715548Q35835937-953A3B6D-EC8E-4F9E-8C40-AB543C9E0BC8Q35878410-5AA4D471-4281-4EE2-B6E2-F0B303D79439Q36001319-BCF60DD6-98BB-468A-A76A-A1F7F3E0C031Q36021034-43A4D4EE-9A65-4E94-A520-33A2D6DC8C8CQ36121346-C4B0D28B-D38D-4DD3-B21B-4F514FF14C60Q36322164-381EB474-FC3D-4966-86E6-0D4DAFACB652Q36464535-995866B0-2A63-4329-A108-4E4BB68FE6B5Q36613581-EB156336-887B-4CAB-8CE3-9D4E8207201FQ36718776-DDC9962D-E900-4821-B237-EDF1948D67CAQ37208778-BCFB5F8D-D83F-4935-BD95-A283A4C2D61AQ37209259-630C4F78-AF2C-4754-88BD-E69183A62784Q37219226-BB14A596-EE96-4EDF-9649-7CBB325F23C8Q37473340-286FEFDB-A5C2-4283-9C80-B62FD516D129Q37918451-7942DACD-44FC-4AC4-9DDF-218B7190481AQ38407335-8822C48D-197A-4BAA-8E13-E7EDE4638642Q38736931-3E8EBCCF-F434-4770-8C30-A6446690B019Q39442418-C49F00BD-73CC-4626-A745-B42714A9BF0DQ40357624-80ADA292-1FB4-46A4-AF07-763E848ADF08
P2860
Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Loss of expression of transfor ...... -situ and invasive carcinomas.
@en
type
label
Loss of expression of transfor ...... -situ and invasive carcinomas.
@en
prefLabel
Loss of expression of transfor ...... -situ and invasive carcinomas.
@en
P2093
P2860
P1433
P1476
Loss of expression of transfor ...... -situ and invasive carcinomas.
@en
P2093
Arteaga CL
Plummer WD Jr
Schuyler PA
Simpson JF
P2860
P304
P356
10.1046/J.1365-2559.2000.00841.X
P577
2000-02-01T00:00:00Z